PSUSA/00000342/202407

Human medicines European public assessment report (EPAR): Bortezomib Fresenius Kabi, bortezomib, Date of authorisation: 14/11/2019, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Docetaxel Accord, docetaxel, Date of authorisation: 22/05/2012, Revision: 19, Status: Authorised

EMEA-003174-PIP01-21-M01

Human medicines European public assessment report (EPAR): Dimethyl fumarate Neuraxpharm, dimethyl fumarate, Date of authorisation: 22/04/2024, Revision: 1, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Ervebo, Ebola Zaire Vaccine (rVSV∆G-ZEBOV-GP, live), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations;Vaccines, PIP number: P/0495/2023

Human medicines European public assessment report (EPAR): Nimenrix, meningococcal groups A, C, W-135 and Y conjugate vaccine, Date of authorisation: 20/04/2012, Revision: 41, Status: Authorised

EMEA-003507-PIP01-23

EMEA-003499-PIP01-23

EMEA-003497-PIP01-23